Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company ad...
Source: businessinsider.com
Prashant Kohli News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Prashant Kohli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Prashant Kohli Today - Breaking & Trending Today
From doomscrolling to thumpstopping: How brands aim to combat digital fatigue
From doomscrolling to thumb-stopping: How brands aim to combat digital fatigue
Source: campaignindia.in
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
New leadership team singularly focused on executing GTX-104 strategyAnnounced alignment with the U.S. Food and Drug Administration (FDA) for Pivot...
Source: businessinsider.com
Acasti appoints WuXi to oversee STRIVE-ON trial
Acasti Pharma, a late-stage biopharma company with drug candidates addressing rare and orphan diseases, has selected WuXi Clinical Development to conduct its STRIVE-ON phase 3 safety trial for GTX-104, a novel injectable nimodipine formulation for intravenous infusion (IV) that addresses high, unmet medical needs for aneurysmal subarachnoid haemorrhage (aSAH).
Source: outsourcing-pharma.com
Acasti Pharma Announces 1-for-6 Reverse Stock Split
/PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (Nasdaq: ACST), a late-stage, biopharma company advancing GTX-104, its novel formulation of...
Source: prnewswire.com